this presentation may contain some forward looking statements, particularly regarding operational...
TRANSCRIPT
This presentation may contain some forward looking statements, particularly regarding operational prospects in 2008 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company’s SEC filings.
BOVIE = ELECTROSURGERY
Surgical instruments in the OR that are related to electrosurgery are called by the name “BOVIE.”
Branding the “Bovie” name within the medical community
Over 32 million surgical procedures in U.S.
Bovie Medical
ICON Generators
TissueResection
ICON GP/VS
CanadayAccessories
Icon GS Plasma
MEG LineInstruments
BovieElectrosurgery
High & Low Temperature Cauteries
Targeted towards the Gastroenterology market.
Over $150 million market including accessories growing 7-9% per year
13,000 operating centers Icon platform provides the
basis to develop customized generators for other specialties (ex. Oncology $200 million).
MEG line of instruments
MEG/Polaris™ Instruments The only product that can compete in
three markets and address all areas of minimally invasive surgeries:
Arthroscopy Instrument Market $200 million Laparoscopy Instrument Market $300 million
Vessel Sealing Market $500 million
Arthroscopy Instrument Market research indicates little
to no innovation from top five companies in this space over the past 15 years.
The only modular arthroscopy instrument available.
Can dramatically reduce cost to the end user.
The only arthroscopy instrument with a flushing port for cleaning.
One tip design can replace multiple instruments.
Laparoscopy Instrument Handle accepts inserts from 2mm
to 12mm Cancelable ratchet feature can be
activated either left or right handed.
Ergonomic handle reduces fatigue and creates more leverage.
Modular design can significantly reduce cost
Metallic handle is electrically isolated to increase instrument life.
Vessel Sealing Instrument Only modular designed laparoscopic VS instrument Handle can accommodate both “open” and
laparoscopic instrument tips. “Seal and Cut” design. Can be used with existing vessel sealing generators
or user can gain enhanced benefits with Bovie generator.
Significantly reduces costs. Largest (total market size $500 million) and fastest
growing (10-15%) segment with highest margins.
•Ergonomic •360 Rotation of cartridge•Electrode quick attachment-detachment•Can be controlled by three triggers:
Jaw triggerCoagulation + sealing triggerPowered blade trigger
Handle & Bovie VS generator provides:
•Cartridge recognition and initial setup•Automatic bipolar cut upon blade advancement•Modulated vessel sealing automatic cycles•Minimal charring and adhesion
Suitable for a variety of endoscopic Bipolar AND Monopolar or Inert applications like
Vessel SealingLaparoscopy
Endo GYNArthroscopy
UrologyThoracic Endoscopy
Sinoscopyand many other open surgery adaptations
Tissue Resection Device
Delivers RF current & sterile saline for resection, hemostatic sealing and coagulation
Lowers blood loss, procedure times and cost savings for hospitals
Liver, pancreatic, kidney tumor removal Orthopedic and laparoscopic surgeries Worldwide market size in 2009 approx. $500
million
ICON GS Plasma System
J-Plasma is formed by holding a sharp conductive point at High Voltage and High Frequency, over which an Inert Gas, such as Helium, flows.
ICON GS Plasma System
Produces a stable thin focused beam of ionized helium gas
Provides minimal invasiveness and precision
No conductive currents during surgery
One working electrode
Canady Technology Agreements
Worldwide distribution and manufacturing agreement for Canady’s plasma related devices and accessories.
Canady Technology will assist in the clinical development of Bovie’s J-Plasma technology.
Canady Technology was the first to demonstrate the utilization of tissue coagulation by argon plasma coagulation via flexible endoscopes.
Bovie Medical Financials
Amex Symbol: BVX Fiscal year 2007 revenues rose to a
record $28.78 million. Net income for fiscal 2007 was
$2,400,591 or $.14 per diluted EPS. 17,600,000 diluted shares
outstanding. 10% insider ownership.
Contact Information
Bovie Medical, Inc. Suite 207, 734 Walt Whitman Road
Melville, NY 11747 800-888-4999
Buttonwood Advisory Group, Inc. 15705 Framingham Lane
Huntersville, NC 28078 800-940-9087